Search

everythinglearnresearchcommunity

for

Search:↓

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

A young woman had a rare tumor causing high male hormone levels and symptoms like excessive hair and acne. After removing the tumor, her hormone levels returned to normal. Early diagnosis is important.

A group has developed therapies that show promise for treating cancer and various other conditions.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Stress hormone CRF can cause hair loss by affecting hair growth cells and hormones.

A woman's small, unnoticed adrenal mass turned out to be a rare non-Hodgkin's lymphoma, treated successfully with surgery and therapy.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Superoxide dismutases help balance cell stress and may aid cancer treatment.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Adrenal tumors should be considered in Addison's disease if unusual results appear, with surgery as a solution.

The document concludes that doctors should thoroughly check postmenopausal women with sudden increased male traits for rare conditions like androgen-producing endometrial cancer.

A patient with myotonic dystrophy had several autoimmune disorders and thyroid cancer, suggesting a possible link between these conditions.